How will COVID-19 affect pharma, and what can pharma marketers do to stay top of mind, while also providing the help searchers need in this uncertain time? Read on to find out.
COVID-19 is accelerating and amplifying healthcare trends, plus creating entirely new ones. In this Intouch POV, we provide strategic and tactical thought-starters for pharma marketers to effectively plan for 2021.
The COVID-19 pandemic has created new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for HCPs and patients faced with navigating their new access and reimbursement realities.
The degree to which healthcare providers are affected by the COVID-19 pandemic depends on a number of factors. It’s important for pharma marketers to understand their mindset in these uncertain times.
New guidance from the FDA and EMA has opened the door to clinical trial protocol flexibility in order to maintain the integrity of the research currently underway. This Intouch POV looks at the challenges & opportunities for pharma marketers.
Team work makes the dream work -- that's what they say, right? But what does it take to make a dream team? Trust, open communication, and the opportunity to fail without fear, say Intouch's Kim Middleton and GSK's Stefanie Nacar.
COVID-19 has upended our healthcare system and thrust pharmaceutical product patient support programs onto the front lines of treatment management. Pharmaceutical companies have the opportunity to demonstrate their commitment to patients and HCPs by ensuring that clear and relevant information is easily available.
During the coronavirus pandemic, one vitally important topic not receiving much public and media attention is how to keep the “at-risk” patient population on therapy. Intouch B2D has a plan.
While pharmaceutical companies have long been the target of public mistrust and negative media attention, right now the industry is doing more than its fair share of rolling up its sleeves to help.
The COVID-19 pandemic is a powerful trigger that will change human behaviors and accelerate adoption of new methods of scientific information-sharing among medical professionals, powered by technology and virtual forms of collaboration. This POV looks at the challenges and opportunities when navigating this new world.